JYRKI HEINÄMÄKI, PhD (Pharm)
Professor of Pharmaceutical nanotechnology
Institute of Pharmacy
Nooruse 1, 50411 Tartu, ESTONIAjyrki.heinamaki [ät] ut.ee
Phone: +372 737 5281
Dr. J. Heinämäki is a full-time Professor of Pharmaceutical nanotechnology and Programme Director of Doctoral Studies in Pharmacy.
Dr. Heinämäki obtained his MSc (Pharm) degree in 1987 and PhD (Pharm) in 1991 at the University of Helsinki, Finland. He received Docentship in Pharmaceutical technology at the University of Helsinki in 1995. In 2010, he was appointed as a full-time Professor in Medical technology for 5 years at the University of Tartu. He holds also an invited professorship (a permanent honorary professorship) at the University of Havana, Cuba since 2008.
Over the last two decades, his research works have focused on pharmaceutical nanotechnology drug delivery systems and oral solid dosage forms, especially in the fields of powder technology, fabrication of nanofibers, granulation, pelletisation, tableting, film coating and surface engineering of pharmaceutical solids. He is also specialized in industrial pharmacy and regulatory processes of medicinal products.
Today, the key research areas of his group are:
In addition, his research team develops and tests novel process analytical technologies (PAT) for nanofabrication processes.
To date, Dr. Heinämäki has authored or co-authored over 110 original peer-reviewed scientific articles in international (category 1.1.) journals, and over 25 articles (extended abstracts) in conference proceedings.
He has also supervised or co-supervised total 19 PhD theses in the abovementioned research fields.
IUT34-18 , Prof. J. Heinämäki, University of Tartu, Faculty of Medicine, Institute of Pharmacy (coordinator).
The project investigates the formulation and manufacturing technologies of new multifunctional nanomedicines potentially applicable in the treatment of the major diseases today.
The project comprises three Work Packages (WPs):
At the end of the project, new nanomaterial drug products and manufacturing technologies for poorly water-soluble drugs and wound healing therapy are developed. Printed personalized medicines intended for pediatric and geriatric drug therapy are available.
Special attention is paid on a high-level research training in pharmaceutical nanotechnology and strengthening the knowledge on this research in Estonia.
This is the research service and collaboration project with the University of Helsinki, Finland.
Group leader at the University of Tartu Prof. J. Heinämäki. Director in charge and project leader Prof. E. Haeggström, University of Helsinki.
The focus of this research project was to develop a multlmodal Acouspin system (USES) that combines intense ultrasound (US) and electrospinning (ES) to generate novel kinds of nanofiber networks intended for acute and/or chronic wound dressings.
The Acouspin technique permits temporal and spatial US control of the structure of nanofibrous platforms and control of the content of individual fibers.
This permits one to modify the rnedranical and micro- and nanotopographic properties of individual fibers and fiber constructs. It is possible to e.g. match the needs of specific tissues and to tune the porosity of the construct to control gas permeatiory cell infiltration, and absorption of wound exudates.